Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later

(MedPage Today) — A single infusion of adeno-associated virus (AAV)-mediated gene therapy led to sustained clinical benefit and no late-onset safety concerns in patients with severe hemophilia B, a longitudinal study showed.
At a median follow…

Source link : https://www.medpagetoday.com/hematologyoncology/hemophilia/116033

Author :

Publish date : 2025-06-12 15:19:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later

Inside the Legal Fight Over the Telehealth Clinics Helping Women Defy Abortion Bans

Sleep Apnea Patients More Ready for GLP-1 Drugs Than Sleep Clinics Are

Related Posts

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

Trump Admin Is Launching a New Private Health Tracking System With Big Tech’s Help

Human trials point the way towards an mRNA vaccine against HIV

Categories

Archives